Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis
Xiaojian Huang(Tongji Hospital), Hongbo You(Tongji Hospital)
Cited by 65
Related Papers
NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway
|Journal of Cellular and Molecular Medicine|2019|47
Histone deacetylase-4 and histone deacetylase-8 regulate interleukin-1β-induced cartilage catabolic degradation through MAPK/JNK and ERK pathways
|International Journal of Molecular Medicine|2018|41
Kaempferol inhibits interleukin‑1β stimulated matrix metalloproteinases by suppressing the MAPK‑associated ERK and P38 signaling pathways
|Molecular Medicine Reports|2018|41
Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis
|Journal of Orthopaedic Surgery and Research|2023|39